• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠出血性大肠杆菌 O111 引起的溶血尿毒综合征患者的细胞因子谱。

Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome.

机构信息

Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Japan.

出版信息

Cytokine. 2012 Dec;60(3):694-700. doi: 10.1016/j.cyto.2012.07.038. Epub 2012 Aug 25.

DOI:10.1016/j.cyto.2012.07.038
PMID:22929411
Abstract

Proinflammatory cytokines are related to the pathogenesis of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic-uremic syndrome (HUS). We assessed the kinetics of the release of cytokines such as neopterin, interleukin (IL)-6, IL-8 and tumour necrosis factor (TNF)-α and the soluble forms of type I and II TNF receptors during EHEC O111-induced HUS (EHEC O111/HUS). Fourteen patients with EHEC O111/HUS were enrolled in this study. Serum concentrations of all cytokines other than TNF-α were significantly elevated in patients with severe HUS compared with those in patients with mild HUS. Although serum concentrations of TNF-α were not significantly higher in patients with severe HUS, most patients with acute encephalopathy showed elevated TNF-α levels. Serum concentrations of these cytokines rapidly and markedly increased, and massive hypercytokinaemia developed 1 day before the diagnosis of HUS in patients with severe HUS. Changes in the number of white blood cells and concentration of serum lactate dehydrogenase were significantly larger between the onset of hemorrhagic colitis and the time of the diagnosis of HUS in patients with severe HUS compared with those in patients with mild HUS. Proinflammatory cytokines play an important role in the pathogenesis of EHEC infection and development of severe complications, including HUS and encephalopathy. Monitoring the cytokine profile may be useful for assessing disease activity of EHEC O111 infections.

摘要

促炎细胞因子与肠出血性大肠杆菌(EHEC)感染和溶血尿毒综合征(HUS)的发病机制有关。我们评估了细胞因子(如新型蝶呤、白细胞介素(IL)-6、IL-8 和肿瘤坏死因子(TNF)-α)以及 I 型和 II 型 TNF 受体可溶性形式在 EHEC O111 诱导的 HUS(EHEC O111/HUS)中的释放动力学。本研究纳入了 14 例 EHEC O111/HUS 患者。与轻度 HUS 患者相比,严重 HUS 患者除 TNF-α外的所有细胞因子的血清浓度均显著升高。尽管严重 HUS 患者的 TNF-α血清浓度没有显著升高,但大多数急性脑病患者的 TNF-α水平升高。这些细胞因子的血清浓度迅速而显著增加,在严重 HUS 患者发生 HUS 诊断前 1 天,出现大量细胞因子血症。与轻度 HUS 患者相比,严重 HUS 患者从出血性结肠炎发病到 HUS 诊断时白细胞计数和血清乳酸脱氢酶浓度的变化明显更大。促炎细胞因子在 EHEC 感染和严重并发症(包括 HUS 和脑病)的发病机制中起重要作用。监测细胞因子谱可能有助于评估 EHEC O111 感染的疾病活动。

相似文献

1
Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome.肠出血性大肠杆菌 O111 引起的溶血尿毒综合征患者的细胞因子谱。
Cytokine. 2012 Dec;60(3):694-700. doi: 10.1016/j.cyto.2012.07.038. Epub 2012 Aug 25.
2
Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy.溶血尿毒综合征伴脑病中可溶性肿瘤坏死因子受体1和金属蛋白酶组织抑制剂-1
J Neuroimmunol. 2008 May 30;196(1-2):147-52. doi: 10.1016/j.jneuroim.2008.02.012. Epub 2008 Apr 14.
3
Serum tau protein as a marker of disease activity in enterohemorrhagic Escherichia coli O111-induced hemolytic uremic syndrome.血清tau蛋白作为肠出血性大肠杆菌O111诱导的溶血性尿毒症综合征疾病活动的标志物。
Neurochem Int. 2015 Jun-Jul;85-86:24-30. doi: 10.1016/j.neuint.2015.04.003. Epub 2015 Apr 17.
4
Extensive serum biomarker analysis in patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome.肠出血性大肠杆菌 O111 感染相关性溶血尿毒综合征患者的广泛血清生物标志物分析。
Cytokine. 2014 Mar;66(1):1-6. doi: 10.1016/j.cyto.2013.12.005. Epub 2013 Dec 31.
5
Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.白细胞介素-33/ST2信号通路促进肠出血性大肠杆菌诱导的溶血尿毒综合征的严重程度。
Clin Exp Nephrol. 2019 Apr;23(4):544-550. doi: 10.1007/s10157-018-1675-y. Epub 2018 Nov 22.
6
Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic induced hemolytic uremic syndrome.血清胰岛素样生长因子结合蛋白 2 水平作为肠出血性大肠杆菌诱导的溶血尿毒综合征疾病严重程度的指标。
Ren Fail. 2021 Dec;43(1):382-387. doi: 10.1080/0886022X.2021.1885445.
7
Hemolytic Uremic Syndrome After an Escherichia coli O111 Outbreak.大肠杆菌O111暴发后出现的溶血性尿毒综合征
Arch Intern Med. 2010 Oct 11;170(18):1656-63. doi: 10.1001/archinternmed.2010.346.
8
[Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection].[智利儿童溶血尿毒综合征中的肠出血性大肠杆菌。感染诊断中不同技术的评估]
Rev Med Chil. 1995 Jan;123(1):13-22.
9
[Evaluation of usefulness of the enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to lipopolysaccharides of Enterohemorrhagic Escherichia coli (EHEC) strains in patients with gastrointestinal disorders and patients with hemolytic uremic syndrome].[酶联免疫吸附测定(ELISA)用于检测胃肠道疾病患者和溶血尿毒综合征患者中针对出血性大肠杆菌(EHEC)菌株脂多糖抗体的实用性评估]
Med Dosw Mikrobiol. 2014;66(3-4):161-75.
10
Enterohemorrhagic Escherichia coli O26:H11-Associated Hemolytic Uremic Syndrome: Bacteriology and Clinical Presentation.肠出血性大肠杆菌 O26:H11 相关溶血尿毒综合征:细菌学和临床表现。
Semin Thromb Hemost. 2010 Sep;36(6):586-93. doi: 10.1055/s-0030-1262880. Epub 2010 Sep 23.

引用本文的文献

1
A Fatal Case of Neuroblastoma Complicated by Posterior Reversible Encephalopathy with Rapidly Evolving Transplantation-Associated Thrombotic Microangiopathy.一例致命性神经母细胞瘤合并后部可逆性脑病及快速进展的移植相关血栓性微血管病
Children (Basel). 2023 Mar 3;10(3):506. doi: 10.3390/children10030506.
2
Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic induced hemolytic uremic syndrome.血清胰岛素样生长因子结合蛋白 2 水平作为肠出血性大肠杆菌诱导的溶血尿毒综合征疾病严重程度的指标。
Ren Fail. 2021 Dec;43(1):382-387. doi: 10.1080/0886022X.2021.1885445.
3
Environmental Cues Modulate Microglial Cell Behavior Upon Shiga Toxin 2 From Enterohemorrhagic Exposure.
环境线索调节志贺毒素 2 暴露后小胶质细胞的行为。
Front Cell Infect Microbiol. 2020 Jan 8;9:442. doi: 10.3389/fcimb.2019.00442. eCollection 2019.
4
Dynamic Gene Network Analysis of Caco-2 Cell Response to Shiga Toxin-Producing -Associated Hemolytic-Uremic Syndrome.产志贺毒素相关溶血尿毒综合征的Caco-2细胞反应的动态基因网络分析
Microorganisms. 2019 Jul 8;7(7):195. doi: 10.3390/microorganisms7070195.
5
Species-specific enhancement of enterohemorrhagic E. coli pathogenesis mediated by microbiome metabolites.微生物组代谢物介导的特定物种增强的肠出血性大肠杆菌发病机制。
Microbiome. 2019 Mar 20;7(1):43. doi: 10.1186/s40168-019-0650-5.
6
Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.白细胞介素-33/ST2信号通路促进肠出血性大肠杆菌诱导的溶血尿毒综合征的严重程度。
Clin Exp Nephrol. 2019 Apr;23(4):544-550. doi: 10.1007/s10157-018-1675-y. Epub 2018 Nov 22.
7
A hemolytic-uremic syndrome-associated strain O113:H21 Shiga toxin-producing Escherichia coli specifically expresses a transcriptional module containing dicA and is related to gene network dysregulation in Caco-2 cells.一株与溶血尿毒综合征相关的产志贺毒素大肠杆菌O113:H21特异性表达一个包含dicA的转录模块,并且与Caco-2细胞中的基因网络失调有关。
PLoS One. 2017 Dec 18;12(12):e0189613. doi: 10.1371/journal.pone.0189613. eCollection 2017.
8
Serum ferritin as an indicator of the development of encephalopathy in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.血清铁蛋白作为肠出血性大肠杆菌诱导的溶血尿毒综合征中脑病发展的指标。
Clin Exp Nephrol. 2017 Dec;21(6):1083-1087. doi: 10.1007/s10157-017-1391-z. Epub 2017 Mar 10.
9
Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.血管生成素-1和-2作为肠出血性大肠杆菌所致溶血尿毒综合征疾病严重程度的标志物
Clin Exp Nephrol. 2017 Feb;21(1):76-82. doi: 10.1007/s10157-016-1254-z. Epub 2016 Mar 5.
10
STEC:O111-HUS complicated by acute encephalopathy in a young girl was successfully treated with a set of hemodiafiltration, steroid pulse, and soluble thrombomodulin under plasma exchange.产志贺毒素大肠杆菌O111:一名患有溶血尿毒综合征并伴有急性脑病的年轻女孩,在血浆置换的同时,通过进行一系列血液透析滤过、类固醇冲击治疗以及使用可溶性血栓调节蛋白,成功得到了救治。
Clin Case Rep. 2015 Apr;3(4):208-12. doi: 10.1002/ccr3.196. Epub 2015 Feb 2.